Wary pharma: AstraZeneca sours on UK

We return to the Los Angeles suburbs that were consumed by wildfires a year ago. The varying rebuilding efforts reveal divides in wealth, but also strains in California’s insurance industry. Never mind the AI job apocalypse, if it comes: the technology will create plenty of new r ...  Show more

The countries have a decades-long relationship—debt freely given in one direction and plenty of oil sold in the other. Yet America’s intervention has served as a reality check on China’s power in Venezuela and elsewhere. Our World Ahead series examines the risks to the American d ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more

Trade ties between <a href="https://www.economist.com/the-americas/2024/11/17/brazil-courts-china-as-its-musk-feud-erupts-again?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term= ...

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ...  Show more